Metlife Inc

Company facts

Industry

Life Insurance

Headquarters

New York, New York

Most recent report

8-K, filed Sep 24, 2026

Incorporated

Delaware

Filings on record

1,000+ filings

On EDGAR

CIK 1099219

Fiscal year ends

December

Filer status

Large accelerated filer

What to read: Jun 2026 10-Q

SECSift found 2 of 11 sections worth reading, with 2 positive, 5 notable, and 2 negative flags.

• Financial Statements (Item 1)

  Full financial statements with all Q2 2026 data, segment results, key disclosures.
  Notable

  • Entered definitive agreement to sell MetLife Ukraine, with a $65M net impairment charge in Q2 2026.
  • Issued $1.0 billion of subordinated debt in February 2026 at 5.850%.
  Negative

  • Unrealized losses on fixed maturity securities without ACL rose $2.6B to $30.7B, driven by higher interest rates.

• Management's Discussion (Item 2)

  Core MD&A with detailed Q2 2026 results, segment data, and liquidity metrics.
  Positive

  • Adjusted earnings available to common shareholders up 15% to $1.6B in Q2 2026 from $1.4B.
  • Group Benefits adjusted earnings up 25% to $503M in Q2 2026 on favorable underwriting.
  Notable

  • Pending disposition of Ukrainian subsidiary PJSC MetLife disclosed.
  • Short-term liquidity $18.8B, liquid assets $182.7B at June 30, 2026.
  • MetLife issued $1.0B of subordinated debt in February 2026.
  Negative

  • Real estate impairment loss was $193M for H1 2026 vs $1M in H1 2025, a sharp increase.

What changed: Jun 2026 vs. Mar 2026

About 10% of MET's Jun 2026 10-Q is new information. 108 paragraphs were added, 302 changed, and 129 removed. Below are the most important lines SECSift identified.

• Item 2 152
• Item 1 130
• Item 4 1
• Item 5 1
• Item 6 1